ARCHIVES

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

Sondik Named Acting DCPC Deputy Director Sinks Leaving at End Of Month; Edwards Costlow Acting Ads

July 21, 1989

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014